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Abstract: Aim: Each year almost 15,000 Danish women are diagnosed with cervical dysplasia, a 
precursor to cervical cancer. The period of medical follow-up, or 'watchful waiting', to monitor for 
regression or progression of the lesion before deciding if treatment by conisation is necessary can be 
long. The aim of this study was to examine the experiences of women with different stages of cervical 
dysplasia and to examine whether their knowledge of human papillomavirus (HPV) as the cause of 
cervical dysplasia influenced their perception of their disease. 
Subject and Methods: We used focus-group and individual interviews with 12 women diagnosed with 
different stages of cervical dysplasia - women who had and had not been conised. Interview guides 
were prepared on the basis of a literature review that identified important issues and questions for the 
participants. 
Results: The participants considered cervical dysplasia to be a highly distressing condition and 
experienced monitoring as a worrying delay before regression of the lesions or treatment could be 
initiated. Women expressed a fear of cancer that was not proportional to the stage of their dysplasia, 
but was determined by their degree of knowledge about their condition. Unlike other sexually 
transmitted diseases, information about HPV did not result in stigmatisation as the perception of this 
disease was dominated by cancer. 
Conclusion: This study showed that it is extremely important to address women's fears, their need for 
information and to ensure better communication with medical practitioners about cervical dysplasia 
immediately after diagnosis, irrespective of the disease stage. 
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Abstract  
Aim: Each year almost 15,000 Danish women are diagnosed with cervical dysplasia, a precursor to cervical cancer. The 
period of medical follow-up, or 'watchful waiting', to monitor for regression or progression of the lesion before deciding 
if treatment by conisation is necessary can be long. The aim of this study was to examine the experiences of women 
with different stages of cervical dysplasia and to examine whether their knowledge of human papillomavirus (HPV) as 
the cause of cervical dysplasia influenced their perception of their disease. 
Subject and Methods: We used focus-group and individual interviews with 12 women diagnosed with different stages 
of cervical dysplasia – women who had and had not been conised. Interview guides were prepared on the basis of a 
literature review that identified important issues and questions for the participants. 
Results: The participants considered cervical dysplasia to be a highly distressing condition and experienced monitoring 
as a worrying delay before regression of the lesions or treatment could be initiated. Women expressed a fear of cancer 
that was not proportional to the stage of their dysplasia, but was determined by their degree of knowledge about their 
condition. Unlike other sexually transmitted diseases, information about HPV did not result in stigmatisation as the 
perception of this disease was dominated by cancer. 
Conclusion: This study showed that it is extremely important to address women’s fears, their need for information and 
to ensure better communication with medical practitioners about cervical dysplasia immediately after diagnosis, 
irrespective of the disease stage. 
[247 words] 
Keywords: cervical dysplasia, human papillomavirus, disease perception 
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Introduction 
Cervical dysplasia, the abnormal growth of cells of the uterine cervix (also known as cervical intraepithelial neoplasia 
or CIN), is a precancerous lesion. It is estimated that 90% of these lesions regress spontaneously while the others 
progress into a more severe lesion and possibly cancer. Persistent infection with human papillomavirus (HPV) is a 
necessary cause of cervical dysplasia (Bosch and Lorincz 2002; Trottier and Franc 2006; Smith et al. 2007). Cervical 
dysplasia can be detected at an early stage by the Papanicolaou (Pap) cytological smear test. It can then be monitored 
regularly for regression of the lesion, or progression, before deciding if treatment by conisation is necessary 
(Bjerregaard 2007; National Board of Health 2007a). The introduction of cervical screening programmes based on the 
Pap smear has resulted in significant reductions in the incidence of cervical cancer, although some 37,000 women in 
Europe still die from this disease each year (Engholm et al. 2008). 
Cervical cancer is the second most common cancer in women worldwide. In Europe the incidence was estimated to be 
33,441 in 2002 (Ferlay et al. 2004). In Denmark, which has a population of about 5 million, the lifetime risk of 
developing cervical cancer is 1%, and every year approximately 400 new cases of cervical cancer are diagnosed and 
about 175 women die from the disease (Clemmensen et al. 2006; National Board of Health 2007b). Since the 
introduction of organized cervical screening for women aged 23–60 years in Denmark in the 1960s, there has been a 
50% decrease in the prevalence of cervical cancer, but the incidence of cervical cancer remains one of the highest in the 
European Union (Engholm et al. 2008; Clemmensen et al. 2006). 
Each year, approximately 14,800 Danish women receive a Pap-smear result that indicates a cervical lesion or 
abnormality of varying degrees of severity (Figure 1) (Clemmensen et al. 2006). The follow-up and clinical 
management of these women depends on the specific cytological changes identified, which are classified according to 
the Bethesda system (National Board of Health 2007a) and explained to the patient as “mild”, “moderate” or “severe” 
cell changes (Figures 1). In the case of mild changes, including atypical squamous cells of undetermined significance 
(ASCUS) atypical glandular cells (AGC), or low-grade squamous intraepithelial lesions (LSIL), the patient is monitored 
by Pap test every 6 months to 1 year to determine whether the dysplasia regresses or progresses. Women with moderate 
changes, such as atypical squamous cells – cannot exclude HSIL (ASC-H) or high-grade squamous intraepithelial lesion 
(HSIL), or severe changes, including adenocarcinoma in situ (AIS), are referred to a private or hospital-based 
gynaecologist who examines the cervix by colposcopy and performs a biopsy. Some women with moderate changes 
(HSIL) may be managed by 'watchful waiting', which involves monitoring by colposcopy every three months, and they 
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 4 
will be treated only if the lesion is seen to progress. Cases of severe dysplasia and cancer in situ are managed by 
conisation (conical section or cone biopsy), which is the surgical removal (under sedation or general anaesthetic) of a 
cone-shaped sample of cervical tissue. This is used as a diagnostics tool and as well as treatment, if the histological 
analysis of the sample shows that all the abnormal tissue has been successfully removed. In Denmark, approximately 1 
in 3 women (5000) with an abnormal Pap result undergo conisation each year (National Board of Health 2007a; Danish 
Gyenecological Cancer 2007; Bro et al. 2008). Currently, HPV testing in the setting of cervical cancer screening is not 
routinely performed in Denmark. 
The period of 'watchful waiting' between diagnosis of a lesion and confirmation of regression or need for treatment may 
last for several years and can be associated with a considerable psychological burden, as suggested by a number of 
studies in the literature (Lauver et al. 1999; French et al. 2004; French et al. 2006; Lerman et al. 1991; Ideström et al. 
2003; Neale et al. 2003; Campion et al. 1988; McCafferty et al. 2004; Fleurence et al. 2007; Hounsgaard et al. 2004; 
Waller et al. 2005; McCafferty et al. 2006). Overall, the results of these mainly quantitative studies show that women 
diagnosed with cervical dysplasia worried about the development of cancer. They often fear death and suffer from 
anxiety, stress and depression associated with worries about their sex life, fertility, medical supervision and potential 
interventions. The results show that women’s lack of knowledge and poor doctor–patient communication can contribute 
the their anxiety (Lauver et al. 1999; French et al. 2004; French et al. 2006; Lerman et al. 1991; Ideström et al. 2003; 
Neale et al. 2003; Campion et al. 1988; McCafferty et al. 2004; Fleurence et al. 2007; Hounsgaard et al. 2004). 
Women’s knowledge about HPV is generally poor (Waller et al. 2005; McCafferty et al. 2006), but providing women 
with information about HPV and its role in cervical dysplasia has been shown to have both positive and negative 
effects. On one hand, a better understanding has been reported to have a negative influence on women’s perception of 
their condition, causing them to perceive it as a stigmatising sexually transmitted disease and producing feelings of 
shame, guilt and low self-esteem (Goffman 1968). Information about the high prevalence of HPV has, on the other 
hand, been reported to improve health-related behaviour (e.g. attendance of organised screening, use of condoms) 
(Waller et al. 2005; McCafferty et al. 2006; Kahn et al. 2007; Maissi et al. 2004; Waller et al. 2007; Clarke et al. 1996; 
McCree et al. 2005; Kahn et al. 2005).  
The aim of this qualitative study, the first of its kind in a Danish context, was to examine the experiences of young 
women aged 25‒35 years diagnosed with cervical dysplasia. In particular we looked at the ways in which they had been 
affected by the diagnosis and subsequent follow-up and treatment. We focused on the women’s own understanding of 
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 5 
the stage of their disease and its course, distinguishing between women who had undergone conisation and those who 
had not. We also sought to determine whether knowledge about HPV affected the women’s perceptions of their disease. 
Patients’ perceptions of a disease are known to be related to their socio-cultural context and these perceptions can 
influence the way in which they cope with the disease (Bishop 1991; Kleinman 1988; Hahn 1984).  
 
Methods 
Qualitative research methods can provide insights into the qualities of a phenomenon and the meanings that patients 
ascribe to it. The results can be generalised analytically, though not statistically (Malterud 2004), and can give a 
detailed understanding of the patients’ perceptions of their illness. We used focus groups and individual interviews to 
obtain as broad a range of perspectives on cervical dysplasia as possible. Focus groups were chosen to create a 
confidential environment in which women could openly discuss their experiences with cervical dysplasia, allowing us 
to gain insights into the social construction of meaning and the perception of this disease among women who had or had 
not undergone conisation, while individual interviews provided additional in-depth narratives about personal 
experiences with cervical dysplasia (Berger and Luckmann 1987; Halkier 2003; Bech et al. 2005; Kvale 1996; Spradley 
1979).  
 
Recruitment of study participants 
The participants were recruited from the practices of three private general practitioners (GPs) and two gynaecologists in 
the cities of Aarhus and Aalborg, Denmark, and from the gynaecology and obstetrics outpatient ward at Skejby hospital, 
Aarhus, Denmark. Women aged between 25 and 35 years, who did not have any serious co-morbidity and who had 
either been diagnosed with cervical dysplasia within the past three months or had had a conical section within the past 
six months were eligible for inclusion. This age range was selected because of the high prevalence of cervical dysplasia. 
We did not seek the official diagnosis for the specific stage of cervical dysplasia for the woman from their medical 
records since what was important was the women’s own understanding of their stage (mild, moderate or severe 
dysplasia) and whether they had or had not been conised. We selected more women who had undergone conisation 
because they would have a longer experience of living with their condition and would be able to talk about how they 
felt before and after the conisation. Women were invited to participate in either an individual interview or in a focus 
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 6 
group. We had individual interviews with one woman who had not undergone conisation, and one who had (table 1). 
Focus groups were organised with people of similar age to improve comparability of results and to facilitate honest and 
open group discussions. Also, since the topic was considered to be personal and potentially sensitive, we decided it was 
important that the focus groups included only a few participants. If the groups are too big one or two participants could 
dominate the discussion or the participants can feel less comfortable talking about sensitive issues (Halkier 2003).  
Women who fulfilled the inclusion criteria were informed orally about the study by the consulting physician who also 
gave them a study information sheet. We gave the physicians an instruction sheet describing how to present the study to 
their patients, underlining that the purpose of the study was to gain in-depth knowledge about the women's disease 
experiences and that no preparation or prior knowledge about cervical dysplasia were required in order to participate. 
Patients wishing to participate then contacted GLM, who was an independent researcher. Anonymity and confidentiality 
were ensured throughout the study. All women gave their informed consent to participate and the study did not require 
ethics committee approval. 
Focus-group and individual interviews 
Semi- and funnel-structured interview guides were used to moderate the focus-groups and structure the individual 
interviews. The topics and questions in the interview guides were selected on the basis of a literature review carried out 
before the start of the study. The questions were open-ended to capture as much information as possible, including any 
that had not been envisaged by pre-interview hypotheses (Halkier 2003; Kvale 1996). Individual interview guides were 
designed to produce an in-depth personal narrative of disease experience, while the focus-group guides were designed 
to facilitate discussion. The guide used for focus-group interviews with women who had undergone conisation is given 
in Table 2 as an example.  
The first focus group was held after working hours in a staff meeting room at Skejby hospital. Although this location 
was chosen as a neutral but familiar environment, the participants appeared to be uncomfortable in this setting and 
subsequent focus groups and interviews were held in small meeting rooms in hotels in Aalborg and Aarhus.  
The focus-group interviews were moderated by GLM with assistance from a colleague. The individual interviews were 
conducted by GLM only. The purpose and design of the study was explained at the beginning of each interview. It was 
emphasized that there were no wrong or right answers to the questions posed and that the aim was to obtain a realistic 
picture of all the participants’ experiences and thoughts on having cervical dysplasia.  
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The interviews were transcribed verbatim and analysed using a discourse theoretical approach to the relationship 
between language and the social construction of meaning (Winther Jørgensen and Phillips 1999). The women’s 
statements were seen as an expression as well as an ongoing construction of the meaning and personal impact of having 
cervical dysplasia. This approach is used to analyse a diversity of statements such that clusters of meaning are generated 
and involves an analysis of the terminology used to speak about the subject and the ways in which it is related to other 
issues. Firstly, the data were coded into the topics that were raised during the discussions. Secondly, the most important 
themes within each topic were identified. Finally, the frequency of and connections between topics and themes were 
analysed. This generated a pattern of the relative meaning that the different topics and themes had for the participants, 
i.e. the women’s most significant experiences associated with having cervical dysplasia. All methodological and 
analytical steps were discussed and alternative interpretations sought with the authors and with an additional 
anthropologist. Disagreements were solved using Spradley’s analytical process of resolution of qualitative data 
(Spradley 1979).  
Results 
In qualitative research, the validity of the results relies more on data collection until no significant new knowledge can 
be generated from it than the number of participants (Malterud 2004; Kvale 1996; Spradley 1979). In the present study, 
this point appeared to be reached after interviews had been conducted with a total of 12 women.  
The characteristics of the women who participated are summarised in Table 1. Of the four participants who had not 
undergone conisation, three women had received their first abnormal smear-test result in the three months before the 
interview. At the time of the study, one of these women had been referred for conisation and two were still waiting for 
the cytology results. One other woman had recently been declared free from cervical dysplasia after three years of 
monitoring. Eight participants had undergone conisation in the six months before the interview. Most of these women 
had received the results of the three-month post-conisation check-up, but none had yet received the results of the six-
month check-up. Three of these women had been referred directly for colposcopy and conisation after receiving the 
initial abnormal smear-test result. The remaining five women had been monitored for one to five years before being 
referred for conisation.  
Two focus-groups were held with women who had undergone conisation, one group with three participants and one 
with four participants. An individual interview was conducted with the remaining woman who had undergone 
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 8 
conisation. One focus-group was held with three women who had not undergone conisation; one individual interview 
was held with a woman who had not undergone conisation. 
The quotes cited below were selected as they illustrate some of the participants’ most important experiences associated 
with being diagnosed with cervical dysplasia. 
Initial reaction to diagnosis of cervical dysplasia 
Most of the participants had reacted with shock, panic or tears when they received the first abnormal smear-test result; 
they said it was like receiving a diagnosis of cancer. Although most of the women knew that this was not the case, fear 
and shock made it difficult for them to understand the explanations provided by the doctor. Many women were quite 
unprepared for an abnormal result because they had considered the test simply as a routine check-up.  
He [the doctor] sat there with my medical record and said: “Well, I see that you have moderate or severe 
cervical dysplasia”. What?! My jaw dropped, my eyes and ears stop working. I could hardly listen because of the 
pounding in my head: “Does this mean I will have cervical cancer soon? Can I have children? Can I do this? 
Can I do that? Am I really that sick? Although I see nothing on the outside, it’s all wrong on the inside. I can’t 
believe I hadn’t noticed anything.” It was really disturbing. It means you can actually walk around and develop 
cancer without knowing it, right? [Woman who had undergone conisation describing her reaction to receiving the 
results of her first colposcopy] 
Even when the initial panic faded, concerns about the evolution of the cervical dysplasia typically persisted. The women 
continued to fear for their lives and their fertility and worried about how much treatment they would have to have and 
for how long they would need medical supervision.  
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Discrepancy between severity of dysplasia and level of anxiety experienced 
Our findings suggest that the severity of cervical dysplasia diagnosed did not correspond to the level of anxiety 
experienced; in fact since some women with low-grade lesions (mild dysplasia) who had not been conised appeared to 
be more anxious than women who had had higher-grade lesions (moderate or severe dysplasia) and had been conised. 
The difference in anxiety level between these women seemed to correspond to the level of their knowledge about 
cervical dysplasia and how long they had been under medical supervision.  
When diagnosed with a low-grade lesion (mild dysplasia), the women said that they had not received much information 
about their condition. At this stage, the women said the follow up period was extremely wearing and full of uncertainty; 
the longer the period of monitoring, the worse they felt. The unknown duration of follow up and the possibility that the 
dysplasia would become more severe were worrying. Most of the women currently on this stage felt that their lives 
were 'on stand-by' and they described themselves as being sad, irritable and anxious. The concerns were particularly 
acute before new tests and when they were waiting for test results, since these events were important milestones. Many 
feared that their condition was constantly progressing and this considerably increased their need for explanations and 
action. At the stage of mild dysplasia, most of the women did not understand the meaning of the test results or the 
justification for the intervals between check-ups. Some thought that the intervals between check-ups were due to the 
problem of waiting-lists in the health-care system. Three women had asked for conisation simply to put an end to the 
waiting because they thought the longer they waited the higher the risk of the condition 'spreading'.  
Several times, I experienced a kind of spontaneous fear of death. All of a sudden, it was like getting a bucket of 
cold water in the face. I’d cry and be sure that it would never turn out well. At the same time, I felt ashamed or 
guilty of making such a fuss about it because I wasn’t really sick. I found that really, really difficult […]. It was a 
great relief [when I was referred for conisation] because at that point, I’d been going to the hospital for nearly 
1½ years. At that stage, my life was being measured by: 'When am I going to the hospital again?' Those 2½ to 3 
months in-between check-ups… A few days before, I’d be really, really upset and be thinking that it was just 
terrible. Then I’d go, and afterwards I walked around feeling pain and bleeding for a few days and then I had to 
wait two weeks to get the test result. I’d be nervous about what I’d be told. […] then it was only 1½‒2 months 
until I had to go back again. All the time, I felt that I was counting down to when it was time to go back. When 
more than a year had passed, I became so upset when I was at the hospital that the doctor said that when I called 
the next time to get the result, I could ask the chief consultant about undergoing conisation before the 
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development of severe dysplasia. And so I did, and he just laughed at me and said that it was the most stupid 
thing he had ever heard. That I shouldn’t make a big deal of it, because it wasn’t like I was sick … Obviously, I 
became extremely upset and I thought: “Well, it's probably just me that’s being stupid”. Then three months 
passed, I went back and it had progressed into severe dysplasia. At that point, I was like, if it can develop one 
stage in three months, I’ll be damned if I want to wait very long for the operation! I was lucky to get a date for 
the surgery within two weeks. But I was like 'phew' [sighing] because they thought I was being ridiculous 
because I wanted the operation before it got to that stage, because I just couldn’t take it anymore. It was too 
hard … It really had a negative impact on my quality of life. [Woman who had undergone conisation] 
Reassuring effect of treatment and more information 
Five of the women who had undergone conisation had been through a long period of follow-up before the decision to 
operate was taken, and they were therefore able to provide insights into their experiences with earlier/milder stages of 
dysplasia. Where mild cervical dysplasia progressed to a higher-grade lesion, the necessity for conisation was upsetting 
but, at the same time, many women felt relief that something was finally being done. The three women who had been 
referred for colposcopy and conisation shortly after the initial smear-test result had also been upset, but they were glad 
that they underwent the operation promptly (typically within two weeks) and that the time of uncertainty was short. The 
women who needed conisation were given more information about cervical dysplasia and the proposed treatment. This 
had a reassuring effect and most of these women thought of conisation as curative and the subsequent medical follow-
up as a precautionary measure.  
At the time of the interviews, most of the participants who had undergone conisation had received a negative test result 
after the three-month post-conisation check-up. Many considered the next check-up at six-months would be a milestone 
after which they hoped to be able to move on with their lives. For most, the diagnosis of their disease made them think 
about what was important in their lives. Some felt unsafe after having had a diagnosis of a potentially fatal disease that 
was not physically visible.  
Effect of information on the mode of transmission of HPV and its role as the cause of cervical dysplasia 
Women who did not know about HPV feared that they were now pre-disposed to developing cancer. For many women, 
the information provided before conisation included the role of HPV as the cause of cervical dysplasia. Learning about 
the sexual mode of transmission of HPV resulted in cervical cancer being seen as an unusual form of cancer. It brought 
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about reflections about infection and re-infection but it did not have adverse psychological effects or cause these women 
to see cervical dysplasia as stigmatising, unlike some other sexually transmitted diseases (McCafferty 2004; Waller 
2005; McCafferty et al. 2006; Goffman 1968; Kahn et al. 2007; Maissi et al. 2004; Waller et al. 2007; Clarke et al. 
1996; McCree et al. 2005; Kahn et al. 2005; Mortensen and Larsen 2008). This was demonstrated by the fact that most 
of the participants had spoken openly about the disease not only with their closest friends and relatives, but also with 
colleagues and fellow students. These women viewed sex as a natural part of life and their perception of their disease 
was dominated by the issue of cancer, not that it was a sexually transmitted disease. 
The role of communication with medical practitioners 
The results from this study indicated that the women’s concerns were dependant on the quality of communication with 
medical practitioners and the amount of information provided. The less the women knew about their condition, the more 
insecure and worried they felt. 
My really sweet gynaecologist said to me: “It’s not like you’re dying, you know?” No, but it really takes up a lot 
of space in my life. I’m not sure that it would have made such a big difference if I had cancer. All the time, I felt 
there was so much uncertainty, uncertainty, uncertainty. I was headed toward something, but what was it? 
[Woman who had undergone conisation describing the period of waiting before the operation] 
Many of the women felt there was a discrepancy between their own reaction of shock and fear and their GP’s relatively 
carefree attitude when they learnt (sometimes over the telephone or from a secretary) about the first abnormal smear-
test result. The women felt the need for clear explanations about the difference between different stages of dysplasia and 
actual cancer. Vague expressions such as a 'precursor to cancer' or a 'precancerous lesion', for instance, was not 
perceived as being essentially different from cancer itself and tended to increase the women’s anxiety. 
The nurse put her hand on my stomach and said: “… it looks exactly as it should”. All the muscles of my body 
relaxed and then she said: “…but I don’t think we’re all the way up there yet”. Then the doctor inserts it a bit 
more and I could easily see [following the images on the monitor] that this tissue didn’t look like the tissue we 
had just seen. And then the doctor went all quiet and I thought: “Well, say something, for God’s sake!” It’s at 
that point that she said: “Well, no, that does not look good at all”. I just felt like crying, because I could see for 
myself that it did look really bad. Then they took the biopsies … And then she said: “If it’s as bad as it seems, I’ll 
call you within ten days.” After that, you just go around in a panic, looking at your phone to see if someone has 
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called, and if it rings you think: “Is it her?” Because that means it’s bad, right? [Woman who had not yet 
received results from a colposcopy] 
The participants said they would have liked more compassion and better verbal and printed information about cervical 
dysplasia at the time of diagnosis. Regardless of the stage of dysplasia, they wanted to know about the medical rationale 
for the intervals between check-ups, the meaning of the test results, the possible consequences for fertility and about 
HPV as the causal factor. Retrospectively, the women who had undergone conisation felt that their anxiety during the 
course of disease had been significantly worsened by poor communication with the various doctors and nurses. Some 
participants suggested that young women in general should be better informed about cervical dysplasia and that more 
women would participate in screening programmes if they knew about the prevalence of HPV and the association of 
HPV with cervical cancer. They also felt that GPs should encourage Pap smear testing when performing other 
gynaecological examinations, for instance. 
Discussion 
The present study is, to our knowledge, the first of its kind to assess and compare the experiences of young Danish 
women diagnosed, via routine cytological screening, with cervical dysplasia of varying grades of severity. The use of 
qualitative research methods has produced an in-depth account of how these young women react to and deal with the 
diagnosis and management of this disease. The results suggest that patients' perceptions of cervical dysplasia 
significantly differ from those of medical professionals and that women’s concerns are not aggravated in proportion to 
the severity of the cervical dysplasia.  
Our results show that the detection of cervical abnormalities, whatever their severity, leads to significant distress and 
anxiety. As other studies have also shown, many women are quite unprepared for the first abnormal result because they 
had considered the test as a routine check-up (French 2006; Hounsgaard 2004).The participants in our study were 
grouped according to whether they had or had not undergone conisation. The results revealed, contrary to what might be 
expected, that women diagnosed with lower-grade lesions and who had not been conised were more likely to experience 
anxiety and stress due to their disease, since they lacked information about their condition and the period of follow-up 
with regular check-ups, before treatment is initiated or before regression of the lesion is confirmed, can be long. From a 
medical viewpoint, 'watchful waiting' is a means of avoiding unnecessary invasive treatment. From the women’s 
viewpoint, their lives during this period of 'watchful waiting' are full of apprehension, waiting for check-ups and the 
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subsequent results and the fear that the lesion will probably 'spread' or develop into cancer. The women diagnosed with 
lower-grade lesions, in particular, had poor understanding of their condition, its cause and the medical rationale for the 
follow-up and treatment provided. Their anxiety was linked to inadequate communication with medical professionals 
(Bunge et al 2009). This is in line with other studies showing that women often have poor understanding of the meaning 
of cervical smear test results (Lauver et al. 1999; French et al. 2004; French et al. 2006; Lerman et al. 1991; Ideström et 
al. 2003; Neale et al. 2003; Campion et al. 1988; McCafferty et al. 2004; Fleurence et al. 2007; Hounsgaard et al. 2004; 
Maissi et al. 2004). 
In this study, women with higher-grade lesions reported less disease-related anxiety after conisation. To some, the 
period of uncertainty had been shorter as prompt treatment (conisation) was given, but most importantly, before 
conisation they had received more information about the causes and clinical management of cervical dysplasia, which 
reassured them. Results from other studies have also suggested that anxiety related to cervical dysplasia is closely 
related to lack of knowledge (Lauver et al. 1999; French et al. 2004; French et al. 2006; Lerman et al. 1991; Ideström et 
al. 2003; Neale et al. 2003; Campion et al. 1988; McCafferty et al. 2004; Fleurence et al. 2007; Hounsgaard et al. 2004). 
Although we cannot exclude negative selection bias i.e. an over-representation of women with negative experiences 
who are more likely to accept to participate, the results from this study do not suggest that there was any. We know that 
focus-group methodology has the risk that unusual experiences are under-reported and negative experiences are over-
reported (Halkier 2003). In this study, the focus group participants did not restrain themselves from expressing singular 
perceptions, Moreover, participants were given the opportunity to express themselves freely, without peer-group 
pressure, in the individual interviews (Bech Risør et al. 2005; Kvale 1996; Spradley 1979).  
This study was based on qualitative methodology and thus included a relatively small number of participants. Many of 
our results agree with those of previous studies and we do not consider that more interviews would have produced more 
qualitative knowledge from women targeted by this study. However, it would be interesting to examine the experiences 
of women who have been monitored for a longer post-operative period. The women in this study who had undergone 
conisation said they imagined that a negative test result for the six-month check-up after conisation would indicate cure 
and thus they could 'start again'. We did not include women who had had the results from this check-up, so we cannot 
say if they would really have felt that way. Results from other studies do not provide clear-cut answers to whether the 
psychological effects of having cervical dysplasia are short-term or of longer duration (Lerman et al. 1991; Ideström et 
al. 2003; Hounsgaard 2004). Further studies should also investigate the experiences of older women and those of 
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women from ethnic minorities and explore the effect of factors such as knowledge of the sexual transmission of HPV on 
their perception of disease.  
Knowing that HPV is the cause of cervical dysplasia did not seem to increase the worries of these young Danish 
women, or lead to feelings of stigma. Some previous studies have suggested that knowing about the sexual transmission 
of HPV can lead to feelings of empowerment and improve health-related behaviour, for example, by encouraging 
condom use and participation in screening programmes for cervical cancer (Kahn et al. 2005). On the other hand, others 
have suggested that this knowledge can lead to women seeing cervical dysplasia as stigmatising (Waller et al. 2005; 
McCafferty et al. 2006; Kahn et al. 2007; Maissi et al. 2004; Waller et al. 2007; Clarke et al. 1996; McCree et al. 2005; 
Kahn et al. 2005) and this may act as a barrier to improved health-related behaviour (Waller et al. 2007). We cannot 
exclude that some women may have not accepted to participate in the present study because of this negative perception. 
Perception of disease is highly dependent on socio-cultural context (Kleinman 1988; Hahn 1984; Berger and Luckmann 
1987) and the young Danish women in our study seemed to have associated cervical dysplasia with cancer rather than 
with a sexually transmitted disease.  
In Denmark, HPV vaccination has been included in the childhood immunisation programme and is, therefore, free-of-
charge since January 2009 for girls aged 12 and for 13-15 year old girls in an initial catch-up programme. Provided that 
women’s participation in the cervical screening programme remains unchanged, vaccination is expected to prevent 
approximately 70% of cervical cancer cases, i.e. those caused by HPV 16 or HPV 18 (Bosch and Lorincz 2002; Trottier 
and Franco 2006; Smith et al. 2007). Our study suggests that the heavy psychological burden experienced by women 
who are diagnosed with cervical dysplasia during cervical screening could also be greatly reduced by vaccination. 
Our study has shown that it is important to address women’s fear of cancer and need for information about cervical 
dysplasia from the moment of diagnosis, regardless of the stage of the lesion. Improved communication may reduce the 
divergence between patients’ and practitioners’ perceptions of cervical dysplasia so that women may understand the 
medical viewpoint of 'watchful waiting' as a reassuring means of monitoring the disease and avoiding unnecessary 
treatment, rather than as a distressing delay. Vaccinated women also need to understand that the vaccine cannot prevent 
all cervical cancers and that it will still be necessary to attend screening. With the proper communication about HPV 
being an extremely prevalent virus that will infect almost everybody during their lifetime (National Board of Health 
2007b), there is a possibility of promoting health care behaviour regarding the uptake of HPV vaccination as well as 
participation in screening programmes for cervical cancer. 
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Figure legends 
 
Fig. 1 The distribution of abnormal results of cervical-smear tests classified according to Bethesda 2006, from Danish 
pathology departments (Source: Recommendations of Cervical Cancer Screening. Copenhagen. National Health Board 
2007b) 
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Fig. 1 Distribution of abnormal Pap-smear results in Danish pathology departments in 2006. Classified according 
to the Bethesda classification 2006 (Source: Recommendations of Cervical Cancer Screening. Copenhagen. National 
Board of Health 2007). ASC atypical squamous cells; AGC atypical glandular cells; LSIL low-grade squamous 
intraepithelial lesions; HSIL high-grade squamous intraepithelial lesion; AIS adenocarcinoma in situ 
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Table 1: Brief description of women included in focus groups or individual interviews 
 
Woman 
number 
Brief description 
Individual interview 
1 Woman who had not undergone conisation: Abnormal smear test result 3 years before the interview, 
declared free of cervical dysplasia 2 weeks before the interview 
5 Woman who had undergone conisation: Monitored for 8 months before conisation and, 3-month 
follow-up results after conisation not received.   
Focus Group 1: women who had not undergone conisation 
2 Abnormal smear test result 8 weeks before the interview, referred for colposcopy 
3 Abnormal smear test result 14 weeks before the interview, waiting for cytology result 
4 Abnormal smear test result 4 weeks before the interview, referred directly for conisation 
Focus Group 2: women who had undergone conisation 
6 Referred directly for colposcopy and conisation after initial abnormal smear test result. 3-month 
follow-up results after conisation showed no dysplasia. 6-month follow-up results not received.  
7 Referred directly for colposcopy and conisation after initial abnormal smear test result. 3-month 
follow-up results after conisation showed no dysplasia. 6-month follow-up results not received.  
8 Monitored for 24 months before conisation. 3-month follow-up results after conisation showed no 
dysplasia. 6-month follow-up results not received. 
Focus Group 3: women who had undergone conisation 
9 Monitored for 18 months before conisation. 3-month follow-up results after conisation showed no 
dysplasia. 6-month follow-up results not received. 
10 Monitored for 12 months before conisation. 3-month follow-up results after conisation showed no 
dysplasia. 6-month follow-up results not received. 
11 Monitored for 60 months before conisation. 3-month follow-up results after conisation showed no 
dysplasia. 6-month follow-up results not received. 
12 Monitored for 3 months before conisation. 3-month follow-up results after conisation showed no 
dysplasia. 6-month follow-up results not received. 
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Table 2: Example of interview guide used for focus groups: women who had undergone a cone biopsy. The other 
interview guides were similar and are available from GLM 
Interview stage Aim Questions 
Opening  Presentation of participants First name, age, how long suffering from cervical dysplasia and when they 
had undergone cone biopsy  
Introductory 
questions 
The participants’ perception 
of cervical dysplasia  
1. Before going on to your personal experiences with cervical dysplasia, 
please describe your views on this disease? 
Cues: precursor or disease in itself, prevalence, consequences, cause, 
treatment options, time to cure 
If woman knows about human papillomavirus:  
2. When did you get the information? 
3. Did it influence your views on cervical dysplasia? 
4. Overall, do you feel you have been well informed about cervical 
dysplasia? 
Transitional questions The participants’ 
experiences with the period 
up to conisation 
5. How did you react when you heard that you had cervical dysplasia? 
6. Can you describe the period prior to conisation? 
7. How did you react to being told that you needed conisation? 
Key questions The effect of cervical 
dysplasia on their quality of 
life after conisation 
8. What are your main thoughts on the disease today? 
Cues: change in perception of cervical dysplasia, termination of or stage in 
the course of disease, future medical supervision, worries about the 
future 
9. Do you feel any physical symptoms or effects from having had cervical 
dysplasia? 
10. Does the dysplasia still affect you psychologically? –If yes, how? 
Cues: frame of mind (fear, shame, guilt, anger, depression), perception of 
self and body, thoughts on the meaning of life, regrets (previous non-
attendance for cervical smear testing), worries about the future, 
disease phobia? 
11. Has cervical dysplasia affected your social life? ‒ If yes, how? 
Cues: Level of support, taboos, concerns about stigma 
12. Has the dysplasia affected your love life? ‒ If yes, how?  
Cues: worries about infidelity, being contagious, conflicts with and 
support from partner, disrupted sex life, fear of rejection 
13. Has there been a change in the way in which cervical dysplasia affects 
you today compared with when you were diagnosed? 
Closing questions  14. In conclusion, how do you assess the communication you had with 
medical practitioners throughout the course of the disease?  
15. Is there anything you think we ought to have discussed but did not? 
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